High-Dose Chemotherapy and Autologous Stem Cell Transplantation in Children with High-Risk or Recurrent Bone and Soft Tissue Sarcomas

Despite increasing evidence that high-dose chemotherapy and autologous stem cell transplantation (HDCT/auto-SCT) might improve the survival of patients with high-risk or recurrent solid tumors, therapy effectiveness for bone and soft tissue sarcoma treatment remains unclear. This study retrospective...

Descripción completa

Detalles Bibliográficos
Autores principales: Choi, Young Bae, Yi, Eun Sang, Lee, Ji Won, Yoo, Keon Hee, Sung, Ki Woong, Koo, Hong Hoe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Academy of Medical Sciences 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4900996/
https://www.ncbi.nlm.nih.gov/pubmed/27366002
http://dx.doi.org/10.3346/jkms.2016.31.7.1055

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4900996/
https://www.ncbi.nlm.nih.gov/pubmed/27366002
http://dx.doi.org/10.3346/jkms.2016.31.7.1055

Ejemplares similares